News and Announcements
SA Capital Initiates Proteomics Research Report
- Published October 06, 2016 9:57AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4th October 2016, ASX Announcement
Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is pleased to advise that SA Capital has initiated coverage on PILL.
BUSINESS MODEL
Proteomics International Laboratories Ltd (PILL) operates in three integrated areas unified by its proprietary proteomicsbased technology platform: diagnostics, analytical services and drug discovery. This sustainable business model sees the Company use revenue generated from analytical services to fund pioneering research into next generation diagnostic assays and drug discovery.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
